Miracle Mile Advisors LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Miracle Mile Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,478 shares of the medical equipment provider’s stock after acquiring an additional 40 shares during the period. Miracle Mile Advisors LLC’s holdings in Intuitive Surgical were worth $590,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Baystate Wealth Management LLC grew its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC grew its stake in shares of Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares during the period. Headinvest LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $28,000. Able Wealth Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Atticus Wealth Management LLC grew its stake in shares of Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 41 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at approximately $9,385,753.30. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Robert Desantis sold 1,498 shares of the stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the sale, the executive vice president now owns 5,507 shares in the company, valued at $2,037,149.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares in the company, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,956 shares of company stock worth $6,927,011. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. BTIG Research boosted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Piper Sandler boosted their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Finally, Citigroup upped their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $403.67.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $436.24 on Tuesday. The firm has a 50-day moving average of $403.83 and a two-hundred day moving average of $383.50. The stock has a market cap of $154.73 billion, a P/E ratio of 78.74, a PEG ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $448.10.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.00 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.